Worldwide Healthcare News

Rise in incidence of needle stick injuries, increase in awareness about smart syringes, and high-end technological advancements drive the growth of the global syringes market. Based on usage, the disposable syringes segment accounted for largest revenue share in 2019. Moreover, the market across North America held the major market share in 2019, and is anticipated to maintain its dominance throughout the forecast period. According to the report, the global  syringes market  size was estimated at $15.34 billion in 2019, and is expected to hit $32.39 billion by 2027, registering a CAGR of 9.6% from 2020 to 2027. Drivers, restraints, and opportunities- Upsurge in incidence of needle stick injuries, rise in awareness about smart syringes, and high-end technological advancements fuel the growth of the global syringes market. On the other hand, high cost and unaffordability of safety syringes and alternative modes of drug delivery impede the growth to some extent. However, increase in need f

Global   nerve repair and regeneration market   accounted for $6.70 billion in 2017 and is expected to reach $13.93 billion by 2023, growing at a CAGR of 13.0% during the forecast period, 2017-2023. The report provides an in-depth analysis of the key winning strategies, drivers & opportunities, market share, key segments, and competitive landscape. The factors propelling the nerve repair and regeneration market are rise in geriatric population, growing prevalence of neurological and epidemic disorders, and introduction of novel and innovative products for nerve repair and regeneration. However, stringent regulatory requirements for product approvals, lack of skilled professionals, and high cost of the devices restrict the market growth. On the other hand, increase in investment by major medical diagnostics giants and improvement in healthcare facilities in Asia-Pacific are likely to offer immense growth opportunities to the market players.     http://Download Sample Report:   https

Dental consumables are dental care products, which are employed during various dental procedures such as dental implants, prosthetics, brushes, crows, and others. They are used by patients suffering from various dental disorders such as dental carries, dental impairment, tooth restoration, and in treatment of associated gingival tissues. The report provides detailed analyses of the top winning strategies, market share & estimations, driving factors & opportunities, key market segments, and competitive landscape. As per the report, the global   dental consumables market   was pegged at $41.06 billion in 2017 and is expected to garner $55.58 billion by 2023, growing at a CAGR of 5.2% through 2023.   High prevalence of dental diseases among geriatric population, surge in dental tourism across emerging economies, and increase in demand for minimally invasive dental procedures drive the growth of the global dental consumables market. Moreover, increase in awareness about oral hygien

  According to the report published by Allied Market Research, the global  Animal Model Market  was estimated at $1.46 billion in 2020, and is anticipated to hit $2.67 billion by 2030, registering a CAGR of 6.1% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.   Download Sample Report at:  https://www.alliedmarketresearch.com/request-sample/8311 Increase in usage of animal models in virology and infectious diseases, rise in adoption of CRISPR technology, and upsurge in likelihood of epidemic or pandemic outbreaks fuel the growth of the global animal model market. On the other hand, regulations and laws for ethical use of animals in research impede the growth to some extent. However, several growth opportunities in the emerging markets have proved to be beneficial for the market. Covid-19 scenario-   The outbreak

    As per the report published by Allied Market Research, the  Cardiac Resynchronization Therapy Market  was pegged at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, growing at a CAGR of 4.9% from 2020 to 2027. Download Sample Report at:  https://www.alliedmarketresearch.com/request-sample/10657 Rise in the geriatric population, increase in the prevalence of cardiovascular diseases, and development in healthcare infrastructure have boosted the growth of the U.S. cardiac resynchronization therapy market. Moreover, high-end technological developments in CRT devices supplemented the market growth. However, product recalls in the U.S., cost of CRT devices, and shortage of healthcare professionals hinder the market growth. On the contrary, developing opportunities in the low economic U.S. states would open lucrative opportunities for the market players.   Covid-19 scenario-   The integration of CRT pacemaker and cardiac resynchronization therapy defibrillator sig

Rise in incidences of kidney diseases, surge in prevalence of lifestyle and chronic diseases, and issues related to kidney transplants drive the growth of the global dialysis market. However, complications in dialysis treatment and reimbursement policy concerns in developing countries hinder the market growth. On the contrary, shift in preference of patients for home hemodialysis and increase in market strategies by market players would open new opportunities in the future. Global  Dialysis Market  was pegged at $91.20 billion in 2020, and is estimated to reach $129.75 billion by 2028, growing at a CAGR of 4.7% from 2021 to 2028. Based on type, the market is divided into hemodialysis and peritoneal dialysis. The hemodialysis segment held the lion’s share in 2020, accounting for more than four-fifths of the market. However, the peritoneal dialysis segment would manifest the highest CAGR of 5.4% during the forecast period. On the basis of product & services, the market is classified

Advancements in R&D in genetic engineering, rise in demand for genetically modified crops, and surge in prevalence of chronic and genetic diseases drive the growth of the global prime editing and CRISPR market. On the other hand, several legal & ethical issues and lack of safety toward gene editing restrain the growth to some extent. However, increase in R&D activities by major key players and decrease in cost of genomic sequencing are expected to create multiple opportunities in the industry. The global  prime editing and CRISPR market  was valued at $2,694.2 million in 2020, and is estimated to reach $23,493.0 million by 2030, growing at a CAGR of 24.3% from 2021 to 2030. Increase in prevalence of sickle cell anemia, advancements in technology for genetics, and surge in awareness regarding gene editing are anticipated to drive growth of the prime editing and CRISPR market. In addition, demand for targeted gene manipulation in biomedical research has led to increase in dem

As per the report, the   lateral flow immunoassay based rapid test industry  was estimated at $4.72 billion in 2018 and is expected to reach $8.49 billion by 2026, growing at a CAGR of 7.6% from 2019 to 2026. The report provides an extensive analysis of the market dynamics including drivers & restraints, major winning strategies, market size & projections, competitive landscape, and major segments.  Advantages of LFIA based rapid tests over laboratory testing, increase in initiatives of government and nonprofit organizations toward health awareness, and surge in healthcare expenditure all over the world drive the growth of the global lateral flow immunoassay based rapid test market. On the other hand, inadequate reimbursement policies for LFIA based rapid test diagnostics restraint the growth to some extent.  However, growth prospects in the developing markets, and rise in prevalence of various chronic and infectious diseases worldwide are estimated to offer a number of opportu

According to the report, the global   surgical lights industry   was estimated at $2.71 billion in 2018, and is projected to garner $3.83 billion by 2026, registering a CAGR of 4.5% from 2019 to 2026. Drivers, restraints, and opportunities- Significant rise in surgical procedures, and surge in technological developments in surgical lights drive the growth of the global surgical lights market. On the other hand,high cost of LED lights restrains the growth to some extent. However, various growth opportunities in emerging economies are expected to create a number of opportunities in the industry.  Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6441   The halogen segment to lead the trail till 2026- Based on type, the halogen segment accounted for more than half of the global surgical lights market share in 2018, and is expected to rule the roost by the end of 2026. This is due to its wide usage in the hospital and ambulatory settings. On the other hand, the

Rise in government support and investment, development of novel vaccines, and growth in immunization programs & their increasing coverage drive the growth of the global   novel vaccine delivery systems market . However, high cost and unaffordability of safety syringes and alternative modes of drug delivery hinder the market growth. On the contrary, FDA approval to Covid-19 vaccine and increase in need for safety syringes in emerging economies would open new opportunities for the market players in the coming years. According to a new report published by Allied Market Research, titled, “Novel Vaccine Delivery Systems Market by Delivery Mode, Device: Global Opportunity Analysis and Industry Forecast, 2021–2030″ the global novel vaccine delivery systems market size was valued at $5,030 million in 2020 and is projected to reach $14,437 million by 2030 registering a CAGR of 10.8% from 2021 to 2030. Download Free [PDF] Sample Copy of the Report to Understand the Structure of the Complete